November 19, 2014
Patrick Kaltenbach, VP and General Manager, Life Science Products and Solutions
Agilent Technologies
5301 Stevens Creek Blvd.
Santa Clara, CA 95051
Cc: Bill Sullivan, CEO; Mike McCullen, CEO-Elect; Darlene Solomon, Chief Technology Officer
Mr. Kaltenbach, Mr. Sullivan, Mr. McCullen, and Ms. Solomon:
The recent and abrupt decision by Agilent to exit the NMR business has negative consequences for all of the stakeholders: the user community, the Agilent employees and Agilent shareholders. Your decision appears toignore the complementary and interrelated nature of experimental analysis, which is inherently strengthened by the use of multiple analytic modalities to improve confidence in results. A case in point is the use in metabolomics of NMR as a complement to mass spectrometry, because quantification of metabolites is inherentlysimpler using NMR than via mass spectrometry. By exiting the NMR business and abandoning a fundamental analytical tool that has served chemistry and biology for over 60 years, Agilent is undermining its stated business objective of providing flexible and powerful solutions to its life sciences and chemistry constituencies. It also greatly diminishes the credibility of Agilent as a reliable partner for any major scientific instrumentation, because it contradicts many unequivocal statements that your company has recently made about its commitment to NMR.
The timing of the announcement also ignores recent developments, including new technologies for further
advancing the utility and sensitivity of NMR analyses that were emerging from Agilent with the potential
to drive further advances, and the recent report from the National Research Council (NRC) recommending
a large federal initiative to advance high magnetic field research. Achieving the aims of the NRC report
is likely to entail investments of $100 million or more in NMR instrumentation.
The negative consequences of your decision fall heavily on the academic & industrial R&D community that
invested in Agilent NMR instrumentation. The cost of converting hundreds of millions of dollars of this legacy equipment to instruments with a future upgrade path – now a virtual monopoly held by Bruker Biospin – is staggering to contemplate. With federal, state and private research support already stretched, this amounts to an unbearable tax on the US research enterprise, where the majority of installed Agilent instrumentation resides.
No one disputes the right and responsibility of Agilent to act in the best interests of its shareholders. However, we vigorously dispute the calculus that leads to the conclusion that the decisions to precipitously close down the MRI and subsequently, NMR, divisions are really in the best longterm interest of Agilent. Indeed, it is clear that the damage that sudden decisions like these which contradict every public statement and assurance made by Agilent’s senior management – will inflict upon Agilent’s NMR customer base will ultimately propagate to other Agilent business lines, because the customers for the other instruments and for NMR instruments are largely one and the same.
In consequence, we urge the management and directors of Agilent to take steps to address the future of the NMR division in a way that responsibly addresses the concerns of all the stakeholders, and will restore the credibility of Agilent as a valued partner. Steps that further hinder the research community, including those which could limit access to parts inventories or restrictions on access to documentation, schematic diagrams, or software, would only exacerbate the damage to Agilent’s credibility. We strongly suggest that Agilent initiate a dialog with the affected NMR community to identify steps that could mitigate the burdens created by this unfortunate decision.
Signees (listed in alphabetical order):
1. Jerome L. Ackerman, Harvard Medical School, United States
2. Bruce Adams, Merck & Co., Inc., United States
3. Hideo Akutsu, Osaka University, Japan
4. Hashim Al-Hashimi, Duke University, United States
5. Andrei Alexandrescu, University of Connecticut, United States
6. Fabio Almeida, Federal University of Rio de Janeiro, Brazil
7. Eugenio Alvarado, University of Michigan, United States
8. Gaya Amarasinghe, Washington University in St Louis, United States
9. Carlos Amero, Universidad Autónoma del Estado de Morelos, Mexico
10. Carlos Amezcua
11. Ian Armitage, University of Minnesota, United States
12. Alexander S. Arseniev, Shemyakin&Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Russian Federation
13. Haribabu Arthanari, Harvard Medical School, United States
14. Sengodagounder Arumugam, University of Louisville, United States
15. Joe Asta, Merck & Co., Inc., United States
16. Hanudatta Atreya, Indian Institute of Science, India
17. Pierre Audet, Université Laval, Canada
18. Michèle Auger, Université Laval, Canada
19. Daina Avizonis, McGill University Goodman Cancer Research Center, Canada
20. David Badger, Ashland Inc., United States
21. Alex D. Bain, McMaster University, Canada
22. Marc Baldus, Utrecht University, The Netherlands
23. Moriah Beck, Wichita State University, United States
24. Bridget Becker, Merck & Co., Inc., United States
25. Ali Haidour Benamin, Universidad de Granada, Spain
26. Irina Bezsonova, University of Connecticut Health Center, United States
27. Robert Bittl, Freie Universität Berlin, Germany
28. Martin Blackledge, Institut de Biologie Structurale, France
29. Chris Blake, Australian National University, Australia
30. Tharin Blumenschein, University of East Anglia, United Kingdom
31. Geoffrey Bodenhausen, Ecole Normale Supérieure- Paris; Ecole Polytechnique Fédérale de Lausanne, France; Switzerland
32. Rolf Boelens, Utrecht University, Netherlands
33. John G. Boylan, Boston University, United States
34. Joe Bozell, University of Tennessee, United States
35. William W. Brey, Florida State University, United States
36. Kevin Brindle, University of Cambridge, United Kingdom
37. Janine Brouilette, Merck & Co., Inc., United States
38. Robert G Bryant, University of Virginia, United States
39. David L. Bryce, University of Ottawa, Canada
40. Alexej Buevich, Merck & Co., Inc., United States
41. Scott Burt, Brigham Young University, United States
42. John Buschweller, Universiy of Virginia, United States
43. Sam Butcher, University of Wisconsin, United States
44. Craig Butts, University of Bristol, United Kingdom
45. Michael Caffrey, University of Illinois at Chicago, United States
46. Sharon Campbell, University of North Carolina, United States
47. Marina Carravetta, University of Southampton, United Kingdom
48. Patrice Castignolles, University of Western Sydney, Australia
49. Silvia Cavagnero, University of Wisconsin, United States
50. K. V. R. Chary, Tata Institute of Fundamental Research, India
51. Fu Chen, The University of Iowa, United States
52. Wei Chen, University of Minnesota & CMRR, United States
53. Zhong Chen, Xiamen University, China
54. Bradley F Chmelka, University of California Santa Barbara, United States
55. James Wing-Yiu Choy, University of Western Ontario, Canada
56. Melanie Cocco, University of California Irvine, United States
57. Ryan Cohen, Merck & Co., Inc., United States
58. Maria R Conte, King’s College London, United States
59. Valérie Copié, Montana State University, United States
60. Florence Cordier, Institut Pasteur, France
61. Gabriel Cornilescu, University of Wisconsin & NMRFAM, United States
62. David Cowburn, Albert Einstein College of Medicine, United States
63. Peter Crowley, National University of Ireland, Ireland
64. Matthew Crump, University of Bristol, United Kingdom
65. Christian Damblon, University of Liège, Belgium
66. Chris Davies, Silantes, United States
67. Ben Davis, Vernalis R&D, United Kingdom
68. Muriel Delepierre, Pasteur Institute, France
69. Marc-André Delsuc, Institute of Genetics and Molecular and Cellular Biology (IGBMC), France
70. Feng Deng, State Key Laboratory of Magnetic Resonance and Molecular and Atomic Physics; National Center for Magnetic Resonance in Wuhan; Wuhan Institute of Physics and Mathematics, China
71. Mandar Deshmukh, CSIR – Centre for Cellular and Molecular Biology, India
72. Thomas Dickinson, Merck & Co., Inc., United States
73. Shangwu (Sam) Ding, National Sun Yat-sen University , Taiwan
74. Peter Dormer, Merck & Co., Inc., United States
75. Nicolas Doucet, INRS-Institut Armand-Frappier & University of Quebec, Canada
76. Martin Dracinsky, Academy of Sciences of the Czech Republic, Czech Republic
77. Venkat Reddy Dudipala, University of Akron, United States
78. Jens Ø. Duus, Technical University of Denmark, Denmark
79. Jane Dyson, The Scripps Research Institute, United States
80. Margaret A. Eastman, Oklahoma State University, United States
81. Arthur S Edison, University of Florida, United States
82. Jeffrey Ellena, University of Virginia, United States
83. Paul Ellis, Doty Scientific, United States
84. Lyndon Emsley, Ecole Normale Supérieure- Lyon; Ecole Polytechnique Fédérale de Lausanne, France, Switzerland
85. Mate Erdelyi, University of Gothenburg, Sweden
86. Richard R. Ernst, ETH Zürich, Switzerland
87. Matthias Ernst, ETH Zürich, Switzerland
88. Matthew Espe, OMNOVA Solutions, United States
89. Andy Evans, Drew University, United States
90. Julie Forman-Kay, Hospital for Sick Children, Canada
91. Andrew Fowler, University of Iowa, United States
92. Ray Freeman, Cambridge, United Kingdom
93. Lucio Frydman, Weizmann Institute of Science, Israel
94. Ernesto Fuentes, University of Iowa, United States
95. George T. Furst, University of Pennsylvania, United States
96. David Fushman, University of Maryland, United States
97. Marion Gaborieau, University of Western Sydney, United States
98. Xinfeng (Frank) Gao, Indiana University, United States
99. Kevin H Gardner, CUNY Advanced Science Research Center, United States
100. Michael Garwood, University of Minnesota, United States
101. Philippe Gaveau, Institut Charles Gerhardt, Universite Montpellier 2, France
102. Kalle Gehring, McGill University, Canada
103. Marco Geppi, Università di Pisa, Italy
104. Carlos F Geraldes, University of Coimbra, Portugal
105. Bahman Ghadirian, University of Western Sydney, Austraila
106. Ion Ghiviriga, University of Florida, United States
107. David Giedroc, Indiana University, United States
108. Lila Gierasch, University of Massachussetts, United States
109. Daniella Goldfarb, Weizmann Institute of Science, Israel
110. Gil Goobes, Bar Ilan University, Israel
111. Boyd Goodson, Southern Illinois University Carbondale , United States
112. Paul Gooley, Bio21 Institute, Australia
113. Natalie Goto, University of Ottawa, Canada
114. Ben Goult, University of Kent, United Kingdom
115. Philip Grandientti, The Ohio State University, United States
116. Hamish Grant, Bio21 Institute, Australia
117. Robert G. Griffin, Massachussetts Institute of Technology, United States
118. Angela Gronenborn, University of Pittsburgh, United States
119. John Gross, University of California, San Francisco
120. Stephan Grzesiek, Biozentrum, University of Basel, Switzerland
121. Ulrich Guenther, University of Birmingham, United Kingdom
122. Iñaki Guijarro, Institut Pasteur (CNRS UMR 3528), France
123. Terrry Gullion, West Virginia University, United States
124. Roberto De Guzman, University of Kansas, United States
125. Raul G. Enriquez Habib, Instituto de Química, UNAM
, Mexico
126. Klaas Hallenga, NMR-Advice, Netherlands
127. Song-I Han, University of California Santa Barbara, United States
128. D Flemming Hansen, University College London, United Kingdom
129. Alex Hansen, The Ohio State University, United States
130. Richard Harris, Vernalis R&D, United Kingdom
131. Emmanuel Hatzakis, Penn State University, United States
132. Sophia Hayes, Washington University St. Louis, United States
133. Gregory Heffron, Harvard Medical School, United States
134. Bert Heise, Spin-Doc Inc., Germany
135. Henrike Heise, Henrich–Heine–Universität Dusseldorf, Germany
136. Gregory Helms, Washington State University, United States
137. Lothar Hennig, Universität Leipzig, Germany
138. Katherine Henzler-Wildman, Washington University in St, Louis
139. Chandralal Hewage, University College Dublin, Ireland
140. Christian Hilty, Texas A&M University, United States
141. Jerry Hirschinger, Purdue University, United States
142. Gina L. Hoatson, College of William and Mary, United States
143. Jeffrey Hoch, University of Connecticut Health Center, United States
144. Markus Hoffmann, The College at Brockport, State University of New York, United States
145. Steve Hollis, , United States
146. Peter Hore, University of Oxford, United Kingdom
147. R. V. Hosur, Tata Institute of Fundamental Research, India
148. Mark Howard, University of Kent, United Kingdom
149. Weidong Hu, City of Hope National Cancer Center, United States
150. Shaw Huang, Harvard University, United States
151. Dennis W Hwang, National Chung-Cheng University, Taiwan
152. Mitsu Ikura, School of Medicine, University of Toronto, Canada
153. Hugo van Ingen, Leiden Institute for Chemistry, Leiden University, The Netherlands
154. Rieko Ishima, University of Pittsburgh, United States
155. Nadia Izadi-Pruneyre, Pasteur Institute, France
156. Hans J Jakobsen, Aarhus University, Denmark
157. Oleg Jardetzky, Stanford University School of Medicine, United States
158. Christopher Jaroniec, The Ohio State University, United States
159. Damien Jeannerat, University of Geneva, Switzerland
160. Jean Jeener, Universite Libre de Bruxelles, Belgium
161. Oliver Jones, RMIT University, Australia
162. Antoni Jurkiewicz, University of Chicago, United States
163. Charalampos Kalodimos, Rutgers University, United States
164. Voula Kanelis, University of Toronto Mississauga, Canada
165. Roger Kautz, Northeastern University, United States
166. Lewis E Kay, University of Toronto, Canada
167. Mark Kelly, University of California San Francisco, United States
168. Arno P. M. Kentgens, Radboud University Nijmegen, The Netherlands
169. Ilkka Kilpeläinen, University of Helsinki, Finland
170. Walter Köckenberger, University of Nottingham, United Kingdom
171. Douglas Kojetin, The Scripps Research Institute, United States
172. Dmitri Korzhnev, University of Connecticut Health Center, United States
173. Wiktor Kozminski, University of Warsaw, Poland
174. Krish Krishnan, California State University Fresno, United States
175. Scott Kroeker, University of Manitoba, Canada
176. Gerard J. Kroon, The Scripps Research Institute, United States
177. Ashutosh Kumar, Indian Institute of Technology, India
178. Kristin Kumashiro, University of Hawaii, United States
179. Tatiana Kutateladze, University of Colorado Anschutz Medical Campus, United States
180. Vladimir Ladizhansky, University of Guelph, Canada
181. Noel Lazo, Clark University, United States
182. Andrew Lee, University of North Carolina, United States
183. Daniel Lee, Commissariat à l'énergie Atomique, Laboratoire de Résonances Magnétiques, Grenoble, France
184. Anne Lesage, ENS-Lyon, France
185. Ewen Lescop, Institute of Chemistry of Natural Compounds, Gif-sur-Yvette, France
186. Malcolm Levitt, University of Southampton, United Kingdom
187. Melissa Lin, Merck & Co., Inc., United States
188. Andrew Lipton, , United States
189. Victor Litvinov, DSM Resolve, Netherlands
190. Yizhou Liu, Merck & Co., Inc., United States
191. David Live, University of Georgia, United States
192. J Patrick Loria, Yale University, United States
193. Lloyd Lumata, UT Dallas, United States
194. Rensheng Luo, University of Missouri-St Louis, United States
195. Xuelian Luo, UT Southwestern Medical Center, United States
196. Burkhard Luy, Karlsruhe Institut für Technologie (KIT), Germany
197. Joel Mackay, University of Sydney, Australia
198. John MacMillan, UT Southwestern Medical Center, United States
199. P. K. Madhu, Tata Institute of Fundamental Research, India
200. Ross Mair, Center for Brain Science, Harvard University, United States
201. Thorsten Maly, Bridge12 Technologies, Inc., United States
202. Suraj Manrao, Stable Isotope Consulting Group, United States
203. Carla Marchioro, Research 4 Rent, Italy
204. Thomas H Mareci, University of Florida, United States
205. Assen Marintchev,
Boston University School of Medicine, United States
206. John Markley, University of Wisconsin, United States
207. Rachel W Martin, University of California Irvine, United States
208. Gary Martin, Merck & Co., Inc., United States
209. Innokently Maslennikov, The Salk Institute for Biological Studies, United States
210. Francesca Massi, University of Massachusetts Medical School, United States
211. Hiroshi Matsuo, University of Minnesota, United States
212. Steve Matthews, Imperial College London, United Kingdom
213. Eugene Mazzola, University of Maryland, United States
214. Ann McDermott, Columbia University, United States
215. Lawrence McIntosh, University of British Columbia, Canada
216. Ryan T. McKay, University of Alberta, Canada
217. Beat H. Meier, ETH Zürich, Switzerland
218. Matthew Merritt, UT Southwestern Medical Center, United States
219. Oscar Millet, CIC bioGUNE, Spain
220. Alain Milon, Université de Toulouse, France
221. Andrew Miranker, Yale University, United States
222. Tony Mittermaier, McGill University, Canada
223. Mehdi Mobli, The University of Queensland, Australia
224. K H Mok, Trinity College Dublin, Ireland
225. Gaetano Montelione, Rutgers University, United States
226. Martha Morton, University of Nebraska - Lincoln, United States
227. Helen Mott, University of Cambridge, United Kingdom
228. Karl Mueller, Penn State University, United States
229. Norbert Mueller, Johannes Kepler University, Austria
230. Ranjith Muhandiram, University of Toronto, Canada
231. Sujoy Mukherjee, Indian Institute of Chemical Biology, India
232. Frans Mulder, Aarhus University, Denmark
233. Kaz Nagashima, Singapore Bioimaging Consortium, Singapore
234. Linda Nicholson, Cornell University, United States
235. Walter Niemczura, University of Hawaii, United States
236. Julie Niere, NMIT University, Australia
237. Luke O’Dell, Deakin University, Austraila
238. Monika Oberer, University of Graz, Austria
239. Dean L Olson, University of Illinois at Urbana-Champaign, United States
240. Vladislav Orekhov, Swedish NMR Centre at Gothenburg University, Sweden
241. Hartmut Oschkinat, Leibniz-Institut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Germany
242. Robert Oswald, Cornell University, United States
243. Michael Overduin, University of Birmingham, United Kingdom
244. Carlos Pacheco, Pennsylvania State University, United States
245. Uresh Parikh, Merck & Co., Inc., United States
246. Carrie Partch, University of California Santa Cruz, United States
247. Eric Paulson, Yale University, United States
248. Spiro Pavlopoulos, Northeastern University, United States
249. Istva'n Pelczer, Princeton University, United States
250. Wolfgang Peti, Brown University, United States
251. Mark Pfuhl, King's College London, United Kingdom
252. Gary Pielak, University of North Carolina Chapel Hill, United States
253. Alex Pines, University of California Berkeley, United States
254. Steve Pitzenberger, Merck & Co., Inc., United States
255. Janez Plavec, Slovenian National Institute of Chemistry, Slovenia
256. Sebastien Poget, CUNY College of Staten Island, United States
257. Tatyana Polenova, University of Delaware, United States
258. Miquel Pons, University of Barcelona, Spain
259. Andrea Porzel, Leibniz Institute of Plant Biochemistry, Germany
260. Carol Post, Purdue University, United States
261. Robert Powers, University of Nebraska, United States
262. James Prestegard, University of Georgia, United States
263. Scott Prosser, University of Toronto, Canada
264. Marek Pruski, Iowa State University, United States
265. Joseph D Puglisi, Stanford University, United States
266. Ishwar Radhakrishnan, Northwestern University, United States
267. S. Raghothama, Indian Institute of Science, India
268. Ayyalusamy Ramamoorthy, University of Michigan, United States
269. Narsimha Reddy, University of Western Sydney, Austraila
270. Mikhail Reibarkh, Merck & Co Inc, United States
271. Jeffrey A Reimer, University of California Berkeley, United States
272. Jimin Ren, UT Southwestern Medical Center, United States
273. Linda Reven, McGill University, Canada
274. William Reynolds, University of Toronto, Canada
275. Chad Rienstra, University of Illinois Champaign-Urbana, United States
276. Christopher Rithner, Colorado State University, United States
277. Edwin Rivera, University of South Florida, United States
278. Jose Rizo-Rey, UT Southwestern Medical Center, United States
279. Gordon Roberts, University of Leicester, United Kingdom
280. Alfredo O Rodriguez, Universidad Autonoma Metropolitana Iztapalapa, Mexico
281. Paolo Rossi, Rutgers University, United States
282. David Rovnyak, Bucknell University, United States
283. Parag Sahasrabudhe, Pfizer, Inc
284. Charles R Sanders, Vanderbilt University School of Medicine, United States
285. Mark R. Sanderson, King's College London, United Kingdom
286. Siddhartha Sarma, Indian Institute of Science, India
287. Josep Sauri, Merck & Co., Inc., United States
288. Paul Schanda, Institut de Biologie Structurale, France
289. Rob Schurko, University of Windsor, Canada
290. Harald Schwalbe, University of Frankfurt, Germany
291. Marco Sette, University of Rome, "Tor Vergata" , Italy
292. N Jon Shah, Juelich-Aachen Research Alliance & Forschungszentrum Juelich GmbH, Germany
293. Gary Shaw, Western University, Canada
294. Dean Sherry, UT Southwestern Medical Center, United States
295. Ichio Shimada, The University of Tokyo, Japan
296. Richard Shoemaker, University of Colorado & AMMRL Steering Committee, United States
297. Ansgar B Siemer, University of Southern California, Keck School of Medicine, United States
298. Heather Simmonite, Vernalis R&D, United Kingdom
299. Jørgen Skibsted, University of Aarhus, Denmark
300. Vladimír Sklenář, National Centre for Biomolecular Research (NCBR), Masaryk University, Brno, Czech Republic
301. Jim Small, Merck & Co., Inc., United States
302. Sergey Smirnov, Western Washington University, United States
303. Brian Smith, University of Glasgow, United Kingdom
304. Steven Smith, Queen’s University, Canada
305. Luis Smith, Clark University, United States
306. Leonard D Spicer, Duke University, United States
307. Remco Sprangers, Max Planck Institute for Developmental Biology, Germany
308. Tara Sprules, Quebec/Eastern Canada High Field NMR Facility, Canada
309. Tim Stait-Gardner, University of Western Sydney, Austraila
310. Siegfried Stapf, Technische Universität Ilmenau, Germany
311. Ruth Stark, CUNY City College, United States
312. Matthias Stoldt, Forschungszentrum Jülich, Germany
313. Martin J. Stone, Monash University, Austraila
314. Yongchao Su, Merck & Co., Inc., United States
315. Michael Summers, University of Maryland Baltimore County & HHMI, United States
316. N. Suryaprakash, Indian Institute of Science, India
317. Brian Sykes, University of Alberta, Canada
318. Susumu Takahashi, University of Southern California, United States
319. Scott Thornburgh, Dow AgroSciences LLC, United States
320. Fang Tian, Penn State University, United States
321. Takuya Torizawa, Chugai Pharmaceutical Co Ltd, Japan
322. Nate Traaseth, New York University, United States
323. Flaviu Turcu, "Babes-Bolyai" University, Romania
324. Marcellus Ubbink, Leiden Institute for Chemistry, Leiden University, The Netherlands
325. Eldon Ulrich, University of Wisconsin & BMRB, United States
326. Sylvia Urban, RMIT University, Australia
327. Jeffrey Urbauer, University of Georgia, United States
328. Kathleen Valentine, University of Pennsylvania, United States
329. Patrick van der Wel, University of Pittsburgh, United States
330. Peter van Zijl, Johns Hopkins University, United States
331. Kristen M Varney, University of Maryland School of Medicine, United States
332. Gianluigi Veglia, University of Minnesota, United States
333. Ron Venters, Duke University, United States
334. José Daniel Figeroa Villar, Instituto Militar de Engenharia Brazil and President – Brazilian NMR Users Association (AUREMN), Brazil
335. Liliya Vugmeyster, University of Alaska Anchorage, United States
336. Gerhard Wagner, Harvard Medical School, United States
337. Li-Qiong Wang, Brown University, United States
338. Keyu Wang, Gilead Sciences, United States
339. Roderick Wasylishen, University of Alberta, Canada
340. Anthony Watts, University of Oxford, United Kingdom
341. David J Weber, University of Maryland School of Medicine, United States
342. Hansjörg Weber, Technical University Graz, Austria
343. Rainer W Wechselberger, Utrecht University, The Netherlands
344. Jörn Werner, University of Southampton, United Kingdom
345. Milo Westler, University of Wisconsin & NMRFAM, United States
346. Dieter Willbold, Institut für Physikalische Biologie, Germany
347. Phillip Williamson, University of Southampton, United Kingdom
348. Robert Thomas Williamson, Merck & Co., Inc., United States
349. William K. Wilson, Rice University, United States
350. Hla Win-Piazza, Western Washington University, United States
351. David Wishart, University of Alberta, Canada
352. Jason C. Woods, Cincinnati Children’s Hospital Medical Center, United States
353. Peter Wright, The Scripps Research Institute, United States
354. Qiong Wu, UT Southwestern Medical Center, United States
355. Deborah Wuttke, University of Colorado, United States
356. Benjamin Wylie, Texas Tech University, United States
357. Shengtian Yang, Novartis Institutes for BioMedical Research, United States
358. Lu Yang, Merck & Co., Inc., United States
359. Yefeng Yao, Shanghai Key Laboratory of Magnetic Resonance / East China Normal University, China
360. Randall Youngman, Corning Inc, United States
361. Victor E Yushmanov, University of Pittsburgh School of Medicine, United States
362. Jaroslav Zajicek, University of Notre Dame, United States
363. Mingjie Zhang, Hong Kong University of Science and Technology, China
364. Qi Zhang, University of North Carolina, United States
365. Wang Zhang, Florida A&M University, United States
366. Pei Zhou, Duke University, United States
367. Xin Zhou, Chinese Academy of Sciences, China
368. Donghua Zhou, Oklahoma State University, United States
369. Kurt Zilm, Yale University, United States
370. Erik Zuiderweg, University of Michigan, United States
371. Markus Zweckstetter, German Center for Neurodegenerative Diseases, Germany
To sign this letter please contact Tatyana Polenova at tpolenov@udel.edu.